<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Characterization Novel Class I Transcription Factor A (CITFA) <br /> Subunit That Is Indispensable Transcription the <br /> Multifunctional RNA Polymerase I Trypanosoma brucei <br /> Tu N. Nguyen,a Bao N. Nguyen,a Ju Huck Lee,a* Aswini K. Panigrahi,c* Arthur G&#195;&#188;nzla,b <br /> Department Genetics Developmental Biology, University Connecticut Health Center, Farmington, Connecticut, USAa; Department Molecular, Microbial and <br /> Structural Biology, University Connecticut Health Center, Farmington, Connecticut, USAb; Seattle Biomedical Research Institute, Seattle, Washington, USAc <br />  <br /> Trypanosoma brucei organism known evolved multifunctional RNA polymerase I (pol I) used <br /> <span id='am-3' about='protege:TO' typeof='owl:Thing'>to</span> express parasite&#226;&#8364;&#8482;s ribosomal RNAs, major cell surface antigens, namely, variant surface glycoprotein <br /> (VSG) procyclin, vital establishing successful infections mammalian host tsetse vector, respec- <br /> tively. Thus far, biochemical analyses T. brucei RNA pol I transcription machinery elucidated subunit structure <br /> of enzyme identified class I transcription factor A (CITFA). CITFA binds RNA pol I promoters, CITFA-2 <br /> subunit shown absolutely essential RNA pol I transcription parasite. Tandem affinity purification (TAP) of <br /> CITFA revealed subunits CITFA-1 -6, conserved kinetoplastid organisms, plus dynein light <br /> chain DYNLL1. Here, tagging CITFA-6 instead CITFA-2, complex purified contained known CITFA subunits, <br /> as novel proline-rich protein. Functional studies carried vivo vitro, colocalization study, un- <br /> equivocally demonstrated protein bona fide CITFA subunit, essential parasite viability indispensable for <br /> RNA pol I transcription ribosomal gene units active VSG expression site mammalian-infective life cycle stage of <br /> the parasite. Interestingly, CITFA-7 function appears species specific, expression <span id='am-238' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-239' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-240' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-241' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-242' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-243' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-244' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-245' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-246' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-247' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-248' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-249' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-250' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-251' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-252' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-253' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-254' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-255' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-256' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-257' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-258' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-259' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-260' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-261' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-262' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-263' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-264' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-265' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-266' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-267' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-268' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-269' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-270' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-271' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-272' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-273' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-274' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-275' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-276' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-277' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-278' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-279' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-280' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-281' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-282' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-283' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-284' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-285' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-286' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-287' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-288' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-289' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-290' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-291' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-292' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-293' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-294' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-295' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-296' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-297' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-298' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-299' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-300' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-301' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-302' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-303' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-304' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-305' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-306' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-307' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-308' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-309' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-310' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-311' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-312' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-313' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-314' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-315' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span>RNA interference</span> (RNAi)- <br /> resistant CITFA-7 transgene Trypanosoma cruzi rescue lethal <span id='am-82' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-83' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-86' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-90' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-91' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-95' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-99' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-103' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-104' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-107' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-110' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-112' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-117' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-122' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-123' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-124' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-125' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-133' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-134' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-142' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-144' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-149' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-150' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-152' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-157' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-159' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span>phenotype</span> silencing endogenous CITFA-7. <br />  <br />  <br />  <br /> I  n eukaryotes, RNA polymerase I (pol I) transcribes exclusively <br />    large ribosomal gene units nucleolus. The unicellular <br /> parasite Trypanosoma brucei exceptional regard because <br />                                                                                    RNA pol I allows parasite express VSG <span id='am-1' about='protege:FROM' typeof='owl:Thing'>from</span> <br />                                                                                    single gene. While mammals RNA pol I unable synthesize <br />                                                                                    functional mRNA (5), deviating gene expression mechanisms <br /> it organism known evolved multifunctional                    trypanosomatids enables T. brucei use RNA pol I for <br /> RNA pol I used rRNA synthesis                       mRNA synthesis. In trypanosomatids, protein-coding genes are <br /> expression proteins crucial parasite&#226;&#8364;&#8482;s successful              arranged long tandem arrays transcribed polycis- <br /> interaction hosts. T. brucei tsetse-borne parasite                tronically, RNA precursors resolved individual <br /> sub-Saharan Africa causes lethal diseases humans live-                 mRNAs spliced leader (SL) trans splicing polyadenylation <br /> stock animals (2). It lives freely mammalian bloodstream                 (reviewed reference 6). While eukaryotes, mRNA cap- <br /> virtue dense coat variant surface glycoprotein (VSG)                 ping occurs cotranscriptionally direct interaction cap- <br /> shields invariant membrane proteins immune recognition                        ping enzymes RNA pol II, SL trans splicing, the <br /> (32) antigenic variation enables parasite evade                   capped, 5=-terminal SL RNA fused 5= end of <br /> the host&#226;&#8364;&#8482;s immune system. There &#226;&#172;&#402;10 million VSG copies                      mRNA, uncouples capping RNA pol II transcription, <br /> the surface bloodstream-form (BF) trypanosome,                   enabling T. brucei RNA pol I express functional mRNA <br /> are expressed single gene drawn repertoire                  (26, 37). <br /> 2,000 VSG genes (16). To accommodate dense coat, active                        The multifunctional RNA pol I T. brucei versatile. <br /> VSG gene, resides 15 telomeric expression sites                    While eukaryotes RNA pol I confined nucleolus, <br /> (ESs) (11), needs transcribed extremely high rates;                transcribes rRNA gene units (RRNAs), active VSG ES <br /> estimated VSG RNA synthesis active ES exceeds                   transcribed outside nucleolus (3) extranucleolar ex- <br /> of single &#226;?&#164;-tubulin gene &#226;&#172;&#402;50-fold (4). This high VSG expres-                  pression site body (ESB), DNase-resistant compartment that <br /> sion required antigenic variation essential BF              appears limit productive transcription single site (17). In <br /> viability itself, VSG silencing led rapid block trypano- <br /> some proliferation culture clearance parasites in- <br /> fected mice (33).                                                                     Received 11 September 2012 Accepted 22 October 2012 <br />     In eukaryotic cells, RNA pol I transcription typically accounts                   Published ahead print 26 October 2012 <br /> for 50% total transcriptional activity,                     Address correspondence Arthur G&#195;&#188;nzl, gunzl@uchc.edu. <br /> the number ribosomal gene units far lower number                       * Present address: Ju Huck Lee, Harvard Medical School, Boston, Massachusetts, <br /> of protein-coding genes. This efficiency RNA pol I                      USA; Aswini K. Panigrahi, KAUST, Thuwal, Saudi Arabia. <br /> appears result high transcription initiation rates,                      Supplemental material article http://ec.asm.org/. <br /> which impressively documented transmission elec-                         Copyright &#194;&#169; 2012, American Society Microbiology. All Rights Reserved. <br /> tron microscopy so-called &#226;&#8364;&#339;Miller spreads&#226;&#8364;? (reviewed refer-                     doi:10.1128/EC.00250-12 <br /> ence 28). It likely high efficiency the <br />  <br />  <br /> December 2012 Volume 11 Number 12                                             Eukaryotic Cell   p. 1573&#226;&#8364;&#8220;1581                                            ec.asm.org     1573 <br />  Nguyen et al. <br />  <br />  <br />  <br /> addition VSG expression, parasite utilizes RNA pol I           untranslated region (UTR) (positions 409 941 relative translation <br /> insect-stage, procyclic form (PF) transcription gene loci         initiation codon) vector pT7-stl (1). Allele deletions were <br /> (25) encode types cell surface antigen procyclin.           achieved transfecting PCR products 100 bp 5= 3= gene <br /> Procylins important parasite establish successful             flanks fused hygromycin phosphotransferase coding region. <br /> infections tsetse vector (27). The RRNA, VSG ES, pro-                 The following DNA oligonucleotides used reverse transcription <br />                                                                              (RT)-PCR: CITFA-7, 5=-TAGGGCCCAGCAACCTTGCCTGCTATATTA <br /> cyclin gene promoters structurally different, suggesting that <br />                                                                              CTTGATACC-3=/5=-TAGGTACCTTGCACTCCTGCGTCGGCCGTGA <br /> they recruit different transcription factors (9). Since two <br />                                                                              GC-3=; CITFA-2, 5=-ATAACTCGGAGACTGACTCG-3=/5=-AACTGGT <br /> promoters absent trypanosomatid organisms Trypano-                GTATTGAACAACG-3=; CITFA-6, 5=-AGAAGCTTACGCGTATGGCT <br /> soma cruzi Leishmania spp., expect T. bru-             GTACAACCGGGAAAGGTG-3=/5=-AGTCTAGACTCGAGGTTATGT <br /> cei-specific proteins VSG ES procyclin gene transcription.           ACCTGAATCCAGCTGTC-3=; Tb927.7.2590, 5=-TCGAGCAACTTGAA <br /> However, proteins involved T. brucei RNA pol I transcrip-             GAGTTACG-3=/ 5=-TCCTGTGGCTTCTGTTCGTTGG-3=; TFIIB, 5=-C <br /> tion far conserved trypanosomatids, suggesting              ACCTCGACTACCACAGATTT TGTTGGGC-3=/5=-TGGTGATCAACG <br /> that fulfill general RNA pol I functions. Alternatively,          TCCTCATACGTGG-3=; TcCITFA-7, 5=-CCTCCCTTTAGCTGCGATG <br /> possible common transcription factors gained specific             CCTAATGTGCGCCGTTGTCGTTGG-3=/5=-TAGCGGCCGCTCCGA <br /> functions protein-coding gene transcription T. brucei evo-            TGACAACTCATTTCCCTCTTG-3=; VSG221, 5=-AGCTTTTTGGCAAC <br /> lution.                                                                      CTCTTTGCCAGG-3=/5=-TGGTAACGCCTGTTTTGCCAGCTATTCC-3=. <br />     Bioinformatic biochemical analysis T. brucei RNA pol I                Cells. BFs cultured HMI-9 medium described previously <br />                                                                              (22). For stable BF transfection, 3 &#226;&#171;&#187; 107 cells, grown exponential phase, <br /> revealed 10 12 core subunits present nuclear <br />                                                                              washed 2 ml Cytomix (120 mM KCl, 0.15 mM CaCl2, 10 mM <br /> RNA Pol (13, 19, 35). The notion missing ortholog the <br />                                                                              K2HPO4, 25 mM HEPES-KOH, pH 7.6, 2 mM EDTA, 5 mM MgCl2), <br /> essential yeast RPA43 subunit replaced T. brucei          resuspended 0.4 ml Cytomix, mixed 10 &#226;?&#174;g linearized plas- <br /> RNA pol II paralog RPB7 (13) substantiated (22).                mid DNA 5 &#226;?&#174;g PCR product. Cells electroporated 1.2 kV, 186 <br /> Instead, essential RNA pol I subunit, termed T. brucei RPA31              &#226;?&#8364;, 50 &#226;?&#174;F BTX ECM600 electroporator, immediately resuspended in <br /> (TbRPA31), novel subunit extremely diver-            50 ml 37&#194;&#176;C prewarmed medium, dispensed 1-ml aliquots into <br /> gent ortholog yeast RPA43, (18). Recently, class I          24-well plates. After incubation overnight, 1 ml antibiotic-contain- <br /> transcription factor A (CITFA) identified; purification led          ing medium added well. Cells selected using G418, <br /> to identification novel subunits, termed CITFA-1 -6,           phleomycin, hygromycin, blasticidin final concentrations 2.5, 1, 1, <br /> plus dynein light chain DYNLL1 (also known LC8) (1).                  2 &#226;?&#174;g/ml, respectively. PF culturing transfection carried out <br /> Tandem affinity-purified CITFA bound 67-bp-long VSG ES                described previously (8, 14). <br /> promoter electrophoretic mobility shift assay, requiring                   In vitro transcription. Preparation transcriptionally active extracts <br />                                                                              cotranscription reactions BES promoter template VSG-trm <br /> both upstream promoter elements efficient binding. The gel <br />                                                                              RNA pol II-recruiting control template SLins19 carried as <br /> shift competed RRNA procyclin gene promot- <br />                                                                              described previously (14). For immunodepletion CITFA-2 and <br /> ers, indicating CITFA general factor RNA pol I tran-           CITFA-7 transcription reactions, extracts prepared cells <br /> scription T. brucei. Accordingly, silencing CITFA-2 expression            exclusively expressing PTP&#226;&#8364;&#8220;CITFA-2 (1) CITFA-7&#226;&#8364;&#8220;PTP depleted <br /> was lethal specifically reduced rRNA VSG mRNA abun-                  IgG beads (GE Healthcare). In parallel, extracts mock treated <br /> dances BFs. Moreover, vitro transcription assays unequivo-             beads. Transcription signals obtained primer extension <br /> cally demonstrated CITFA-2 absolutely required                  32P-end-labeled oligonucleotides Tag-PE SLtag, hybrid- <br /> transcription types RNA pol I promoters (1).               ize unrelated oligonucleotide insertions VSG-trm SLins19 <br />     Here identified novel, proline-rich protein co-           RNAs, respectively. Primer extension products separated de- <br /> purified CITFA-6 extract. The protein known                 naturing 50% urea&#226;&#8364;&#8220; 6% polyacrylamide gels detected autora- <br /> protein domains conserved trypanosomatids.                 diography. <br /> Our data protein bona fide CITFA subunit                 RNA analysis. Total RNA preparation hot phenol method and <br />                                                                              Northern blot primer extension analyses carried previ- <br /> essential RRNA VSG transcription BFs. Interestingly, <br />                                                                              ously described (1, 18). Reverse transcription total RNA using <br /> CITFA-7 silencing rescued RNA interference (RNAi)-                 SuperScript II reverse transcriptase (Invitrogen), following manufac- <br /> resistant T. brucei CITFA-7 (TbCITFA-7) transgene             turer&#226;&#8364;&#8482;s recommendations. <br /> heterologous T. cruzi ortholog (TcCITFA-7). While data sug-                  Antibodies. For generation immune sera, full-<span id='am-2' about='xsp:length' typeof='owl:Thing'>length</span> CITFA-6 <br /> gest TcCITFA-7 generally defective T. brucei, ex-           CITFA-7 recombinantly expressed Escherichia coli an <br /> periment confirmed previous observations mammals es-                 N-terminal glutathione S-transferase (GST) tag purified glutathi- <br /> sential functions RNA pol I transcription diverge rapidly            affinity chromatography. The GST fusion proteins used im- <br /> (10).                                                                        munizing rats published previously (29). In addition immune <br />                                                                              sera, immunoblot detections carried polyclonal antibodies <br /> MATERIALS AND METHODS                                                        directed CITFA-2 (1), TFIIB (29), spliceosomal protein <br /> DNAs. pCITFA-6-PTP-NEO described previously (1). pCITFA-7-               U2A= (also known U2-40K [20]). The PTP tag detected with <br /> PTP-NEO pCITFA-7-HA-BLA generated inserting 353 bp            monoclonal anti-protein C epitope antibody (Roche) per- <br /> the CITFA-7 coding region (position 56 position 408) ApaI    oxidase antiperoxidase reagent (Sigma). For hemagglutinin (HA) tag de- <br /> NotI sites vectors pC-PTP-NEO (31) pC-HA-BLA (18), respec-            tection, rat monoclonal anti-HA antibody used (Roche). <br /> tively. As for, pTcCITFA-7-HA-bla, 543 bp T. brucei CITFA-7 5=            Protein analysis. Extract preparation CITFA-6-P CITFA-7- <br /> gene flank fused T. cruzi CITFA-7 open reading frame (ORF)     PTP tandem affinity purifications conducted according stan- <br /> overlap PCR. The product cloned vector pC-HA-BLA                dard protocol (31). Purified proteins separated SDS&#226;&#8364;&#8220;10 20% <br /> through ApaI NotI sites. The construct linearized MscI site   polyacrylamide gradient gels stained Coomassie blue (Gelcode <br /> for integration T. brucei CITFA-7 locus. The RNAi vector            Coomassie stain; Thermo Fisher Scientific). For protein identification, <br /> pCITFA-7-T7-stl generated inserting 533 bp CITFA-7 3=          protein bands excised gels, digested trypsin, subjected <br />  <br />  <br /> 1574   ec.asm.org                                                                                                                          Eukaryotic Cell <br />                                                                                                                                A Novel CITFA Subunit T. brucei <br />  <br />  <br />  <br />  <br /> FIG 1 Identification CITFA-7. (A) Tandem affinity purification CITFA-6 &#226;&#8364;&#8220;PTP. Purified proteins separated SDS-PAGE stained with <br /> Coomassie blue. For comparison, 0.002% crude extract (Inp) 5% TEV protease eluate coanalyzed. On right, mass spectrometric protein <br /> identifications CITFA-1 -7, DYNLL1, CITFA-2 degradation products (2-deg) indicated. (B) Reciprocal co-IP CITFA-7&#226;&#8364;&#8220;HA PTP&#226;&#8364;&#8220;CITFA-2 <br /> from PF BF extracts. The immunoblot analysis includes equal amounts starting material (Inp) supernatant (S) 5-fold enrichment the <br /> precipitate (P). Detection RNA pol II transcription factor TFIIB served negative control. (C) Multiple sequence alignment trypanosomatid CITFA-7 <br /> orthologs T. brucei (accession numbers listed Table S1 supplemental material), T. congolense (Tco), T. vivax (Tv), T. cruzi (Tc), Leishmania <br /> major (Lm), L. infantum (Li), L. braziliensis (Lb). Positions 50% identity similarity shaded black gray, respectively. Overall <br /> identity/similarity values specified end sequence determined pairwise comparison T. brucei sequence using EMBOSS software <br /> program (http://www.ebi.ac.uk/emboss/align/) default settings. Dashes indicate sequence gaps. Numbers parentheses specify number residues without <br /> significant sequence similarity. Asterisks mark 13 invariant proline positions. <br />  <br />  <br /> to liquid chromatography-tandem mass spectrometry. The resulting data            RESULTS <br /> were analyzed using TurboSEQUEST program BioWorks 3.1                 Identification novel CITFA subunit. CITFA originally <br /> software package (Thermo Fisher Scientific). Coimmunoprecipitations              characterized tandem affinity purification tagged CITFA-2. <br /> (co-IPs) carried previously published (18), BF extract <br />                                                                                  To confirm nature complex, tandem affinity <br /> was prepared recently described (21). Sucrose sedimentation per- <br /> formed exactly previously procyclic extract (1). <br />                                                                                  purified conserved subunit, CITFA-6, been <br />      Immunofluorescence microscopy. BFs grown exponential phase               C-terminally fused composite PTP tag consisting tan- <br /> were centrifuged 800 &#226;&#171;&#187; g 5 min, washed ice-cold phosphate-             dem protein A (ProtA) domain, TEV protease cleavage site, and <br /> buffered saline (PBS), fixed adding formaldehyde final con-          protein C epitope (ProtC [31]). CITFA-1 -6 DYNLL1 <br /> centration 2% 10 min room temperature. Fixation termi-             recovered final eluate addition fainter bands <br /> nated adding glycine final concentration 125 mM 5 min.            35 kDa band &#226;&#172;&#402;17.5 kDa (Fig. 1A). Liquid <br /> Cells washed times PBS resuspended PBS          chromatography-tandem mass spectrometry revealed the <br /> density 3 &#226;&#171;&#187; 107 cells/ml. Cells (5 &#226;&#171;&#187; 106) spotted silanized         larger bands specific degradation products CITFA-2, <br /> coverslips (Thermo Fisher Scientific) allowed settle 30 min,          17.5-kDa band identified new protein was <br /> after coverslips washed twice PBS 5 min each. To <br />                                                                                  termed CITFA-7 (accession number Tb927.7.2600). <br /> reduce spherical aberrations cells, coverslips placed 24-well <br /> plate centrifuged 2 min 800 &#226;&#171;&#187; g (12). After 10-min rehydra-             While apparent size CITFA-7 range its <br /> tion PBS, fixed cells permeabilized 0.1% NP-40-containing PBS         predicted mass 15.1 kDa, identification based a <br /> for exactly 5 min, washed twice PBS, blocked PBG (PBS containing           single, partially tryptic peptide match (data shown). To con- <br /> 0.5% bovine serum albumin [BSA] 0.2% cold water fish gelatin;                firm correct protein identified, generated PF and <br /> Sigma), incubated consecutively primary secondary anti-             BF cell lines CITFA-2 -7 PTP HA tagged, <br /> bodies diluted PBG. Coverslips extensively washed PBS         respectively. Reciprocal coimmunoprecipitation (co-IP) assays <br /> each antibody probing finally mounted slide VectaShield          extracts prepared cells unequivocally demon- <br /> (Vector lab). PTP-tagged proteins detected polyclonal anti-          strated interaction proteins (Fig. 1B). Except the <br /> protein A immune serum (Sigma) followed Alexa 594-conjugated               C terminus, CITFA-7&#226;&#8364;&#8482;s amino acid sequence highly con- <br /> anti-rabbit secondary antibody (Invitrogen), HA-tagged CITFA-7 <br />                                                                                  served members Trypanosomatidae se- <br /> was detected above-specified anti-HA antibody Alexa <br /> 488-conjugated anti-rat secondary antibody (Invitrogen). Immunofluo-             quence similarity proteins outside phylogenetic family. <br /> rescence assays procyclics described previously (15). Im-        Furthermore, CITFA-7 does contain sequence motifs of <br /> ages acquired Zeiss AxioVert 200 microscope, colocaliza-           known function does contain 13 proline residues are <br /> tions quantified using Zeiss Axiovision 4.6.3.0 colocalization          absolutely conserved trypanosomatid orthologs (Fig. 1C). <br /> software program.                                                                    CITFA-7 bona fide subunit CITFA. Since CITFA-7 was <br />  <br />  <br /> December 2012 Volume 11 Number 12                                                                                                             ec.asm.org 1575 <br />  Nguyen et al. <br />  <br />  <br />  <br />  <br /> FIG 2 CITFA-7 bona fide subunit CITFA. (A) Schematic drawing CITFA-7 wild-type (WT) allele allele modifications cell line TbC7ee, <br /> which exclusively expresses CITFA-7&#226;&#8364;&#8220;PTP untagged CITFA-7. The CITFA-7 coding region, HYGR NEOR genes, PTP tag sequence are <br /> depicted open boxes, striped boxes, black box, respectively. Gene flanks RNA processing signals indicated smaller gray boxes. (B) Immunoblot <br /> analysis whole-cell lysates wild-type procyclic cells TbC7ee cells using newly generated polyclonal anti-CITFA-7 immune serum (&#226;?&#163; CITFA-7) and <br /> a commercially available (Roche), monoclonal anti-ProtC antibody (&#226;?&#163; ProtC). (C) Immunoblot monitoring CITFA-7&#226;&#8364;&#8220;PTP purification (note TEV <br /> protease digest reduced CITFA-7&#226;&#8364;&#8220;PTP CITFA-7&#226;&#8364;&#8220;P). Aliquots crude extract (Inp), flowthrough IgG affinity chromatography (FT-IgG), TEV <br /> protease elution (TEV), flowthrough anti-ProtC affinity chromatography (FT-ProtC), final eluate (Elu) separated 10% SDS- <br /> polyacrylamide gel, blotted, probed anti-ProtC antibody. The blot reprobed immune sera directed CITFA-2 CITFA-6. Arrows <br /> point FT-IgG signals indicating codepletion subunits. (D) Protein analysis CITFA-7 TAP, analogous CITFA-6 TAP Fig. 1A. (E) Anti-ProtC <br /> immunoblot final eluate CITFA-7&#226;&#8364;&#8220;PTP purification. The purified complex left untreated incubated alkaline phosphatase (AP) (from <br /> calf intestine) AP phosphatase inhibitor cocktail (ph-inh). <br />  <br />  <br />  <br /> not detected CITFA-2 tandem affinity purification (1) co-                 However, faint band just main band resolved, <br /> purified CITFA-6 substoichiometric amounts (Fig. 1A),                 suggesting CITFA-7 carries modification than <br /> was possible represented distinct factor interacted               phosphates. <br /> with CITFA complex. To explore possibility, tagged                      Monitoring PTP tandem affinity purification immuno- <br /> and tandem affinity purified CITFA-7. We generated PF cell               blotting showed CITFA-7&#226;&#8364;&#8220;PTP, reduced to <br /> line, termed TbC7ee, exclusively expressed CITFA-7                  CITFA-7&#226;&#8364;&#8220;P TEV protease elution, efficiently purified in <br /> C-terminal PTP tag. This achieved integrating plasmid                 chromatography steps (Fig. 2C, upper panel). When blot <br /> pCITFA-7-PTP-NEO CITFA-7 allele knocking                         shown Fig. 2C reprobed polyclonal anti-CITFA-2 <br /> out remaining CITFA-7 wild-type allele hygromycin                   antibody (1), apparent CITFA-2 efficiently <br /> phosphotransferase (HYGR) marker (Fig. 2A). As molecular                       codepleted extract (Fig. 2C, middle panel, arrow). To <br /> tool, raised specific anti-CITFA-7 immune serum rats                 analyze finding extended CITFA subunits, <br /> confirmed TbC7ee cells did express wild-type, untagged                  raised specific polyclonal anti-CITFA-6 immune serum in <br /> CITFA-7 (Fig. 2B). Since CITFA-7 encoded essential gene                 rats (see Fig. S1 supplemental material). Reprobing blot <br /> (see below), concluded tag did interfere                    antiserum showed codepletion CITFA-6 (Fig. <br /> CITFA-7 function. Both anti-ProtC anti-CITFA-7 antibodies                    2C, lower panel). As follows, CITFA complex quantitatively <br /> detected wild-type tagged CITFA-7 distinct, nar-                associated tagged CITFA-7. Furthermore, protein profile <br /> rowly spaced bands. This <span id='am-316' about='xsp:pattern' typeof='owl:Thing'>pattern</span> primarily result multiple             CITFA-7 purification revealed CITFA sub- <br /> CITFA-7 phosphorylations, treatment alkaline phos-                    units copurified apparently stoichiometric amounts, with <br /> phatase resolved larger bands lower band (Fig. 2E).                 major protein bands detectable (Fig. 2D). We concluded <br />  <br />  <br /> 1576   ec.asm.org                                                                                                                                 Eukaryotic Cell <br />                                                                                                                                    A Novel CITFA Subunit T. brucei <br />  <br />  <br />  <br />  <br /> FIG 3 CITFA-7 silencing lethal, leading specific loss RNA pol I-synthesized transcripts. (A) Growth curves clonal BF cell line absence (-Dox, <br /> blue) presence (&#226;&#171;&#185;Dox, red) doxycyline, which, line, induces synthesis CITFA-7 dsRNA targets 3= UTR corresponding mRNA. <br /> The <span id='am-160' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-161' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-162' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-164' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-167' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-169' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-174' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-175' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-177' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-178' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-179' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-181' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-185' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-188' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-189' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-200' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-203' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-205' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-206' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-207' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-209' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-211' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-217' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-218' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-222' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-226' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-229' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-236' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span>lethal phenotype</span> presence doxycycline rescued (Rescue &#226;&#171;&#185;Dox, green) fusing HA tag sequence RPA1 3= UTR endogenous <br /> CITFA-7 allele. In schematic wild-type modified CITFA-7 mRNAs (not scale), coding region depicted gray box wild-type UTRs as <br /> black lines, capped spliced leader drawn cyan, poly(A) tail indicated AAA. In modified mRNA, HA coding sequence modified 3= UTR <br /> are drawn green. (B) Semiquantitative RT-PCR analysis CITFA-7, CITFA-2, CITFA-6 mRNA levels total RNA prepared cells CITFA-7 <br /> was silenced specified periods. In addition, mRNA abundance gene Tb927.7.2590, downstream, tandemly linked gene CITFA-7, <br /> and TFIIB, independent control, determined. post ind., postinduction. (C) Anti-HA immunoblot analysis whole-cell lysates prepared rescued <br /> cells induced doxycycline specified periods expressed CITFA-7&#226;&#8364;&#8220;HA RNAi-resistant mRNA. U2A= detection blot <br /> served loading control. (D) Analysis total RNA prepared CITFA-7-silenced cells. rRNA detected ethidium bromide staining, VSG mRNA and <br /> mRNA spliceosomal protein SmD1 Northern blotting, SL RNA U2 snRNA primer extension analysis. <br />  <br />  <br />  <br /> that CITFA-7 bona fide subunit CITFA complex. It                       gene modification achieved targeted integration plas- <br /> appears tagging CITFA-2 lesser extent tagging                  mid CITFA-7 locus fused HA tag sequence the <br /> CITFA-6 destabilized CITFA-7 binding CITFA complex,                         3= flank gene encoding largest RNA pol I subunit RPA1 <br /> leading partial losses CITFA-7 corresponding purifi-                  CITFA-7 allele. As shown Fig. 3C, abundance of <br /> cations.                                                                           HA-tagged CITFA-7 did decrease doxycycline induc- <br />     CITFA-7 essential trypanosome viability RNA pol                     tion. We concluded CITFA-7 essential the <br /> I-mediated gene expression. To address CITFA-7                       viability BFs. The essentiality CITFA-7 appears extend to <br /> essential component CITFA, silenced CITFA-7 expression                       PFs well, corresponding knockdown life cycle <br /> in BFs conditional, doxycycline-induced expression                           stage halted culture growth 3 days (see Fig. S2 supple- <br /> CITFA-7 double-stranded RNA (dsRNA) (36), targeting 3=                         mental material). <br /> UTR CITFA-7 mRNA RNAi pathway. We obtained                              Further analysis total RNA prepared CITFA-7-silenced <br /> a single clonal cell line proliferation ceased 1 day            BFs showed RNA pol I transcripts rRNA VSG mRNA <br /> of doxycycline induction, noninduced cells prolifer-                   abundant doxycycline induction (Fig. 3D). In <br /> ated logarithmically 3-day period experi-                    samples containing equal amounts RNA, compensa- <br /> ment (Fig. 3A). The lethal phenotype appeared to                         tory increases relative abundance observed RNA <br /> CITFA-7 silencing CITFA-7 mRNA level strongly                      pol II-synthesized SmD1 mRNA, encoding RNA splicing pro- <br /> reduced 24 h doxycycline induction mRNA abun-                        tein, SL RNA, RNA pol III-synthesized U2 <br /> dances gene downstream adjacent CITFA-7                       snRNA. Since corresponding results obtained loss of <br /> CITFA-2, CITFA-6, TFIIB control affected (Fig.                    CITFA-2 (1) RNA pol I subunit RPA31 (18), profile of <br /> 3B). To unequivocally demonstrate lethal effect spe-                  RNA abundances strongly indicated CITFA-7 essential for <br /> cific CITFA-7 silencing opposed nonspecific off-target                  RNA pol I transcription. <br /> siRNA effect, manipulated CITFA-7 allele &#226;&#8364;&#339;RNAi&#226;&#8364;?                          CITFA-7 colocalizes CITFA-2 RNA pol I subunit <br /> cell line create RNAi-resistant CITFA-7 mRNA fully                     RPB6z nucleolus. Thus far, localization CITFA sub- <br /> restored cell growth presence doxycycline (Fig. 3A). The                 units investigated. To facilitate analysis, we <br />  <br />  <br /> December 2012 Volume 11 Number 12                                                                                                                 ec.asm.org 1577 <br />  Nguyen et al. <br />  <br />  <br />  <br />  <br /> FIG 4 CITFA-7 colocalizations. (A) Colocalization PTP-RPB6z (red) with <br /> CITFA-7&#226;&#8364;&#8220;HA (green). (B) Colocalization PTP&#226;&#8364;&#8220;CITFA-2 (red) CITFA- <br /> 7&#226;&#8364;&#8220;HA (green). White bars represent 10 &#226;?&#174;m. <br />                                                                             FIG 5 CITFA-7 essential RNA pol I transcription. Cotranscriptions of <br />                                                                             VSG ES promoter template VSG-trm RNA pol II control template SLins19 <br />                                                                             extracts mock depleted (mock), immunodepleted (depl) of <br />                                                                             CITFA-2 CITFA-7, reconstituted buffer final eluates (elu) of <br /> generated BF cell lines CITFA-7 C-ter-             PTP&#226;&#8364;&#8220;CITFA-2 CITFA-7&#226;&#8364;&#8220;PTP TAPs (top panel). Anti-CITFA-2 (middle <br /> minally HA tagged RPB6z CITFA-2 N-termi-                  panel) anti-CITFA-7 (bottom panel) immunoblots depleted recon- <br /> nally PTP tagged. These tags functional, exclusive           stituted extracts detecting endogenous, PTP-tagged, P-tagged (after TEV <br /> expression tagged versions essential proteins did           protease digest) proteins shown. <br /> not impair proliferation cultured trypanosomes (1, 18; this <br /> study). In 4=,6-diamidino-2-phenylindole (DAPI) stains the <br /> nucleus, nucleolus recognized spherical structure        concentrated nucleolus ESB (Fig. 4B, second panel <br /> low DNA density (Fig. 4). As expected, RNA pol I subunit                set; data shown). <br /> RPB6z localized consistently nucleolus, cases               CITFA-7 depletion extract abolishes RNA Pol I tran- <br /> an accumulation nucleolar periphery (Fig. 4A),           scription vitro. To verify essential transcription function of <br /> observed (23). The tagged CITFA-7 subunit exhibited                CITFA-7, depleted CITFA-7 extracts prepared from <br /> similar distribution, colocalization CITFA-7 RPB6z               TbC7ee cells. Cotranscription VSG ES promoter template <br /> was calculated approximately 50% protein (see Fig.           VSG-trm RNA pol II-recruiting template SLins19, har- <br /> S3 supplemental material). This partial overlap consistent        boring SL RNA gene promoter, showed depletion of <br /> with CITFA promoter-binding transcription initiation                CITFA-7 extract virtually abolished VSG-trm transcription <br /> factor associated transcribing RNA pol I. As ex-               affecting SLins19 transcription (Fig. 5, compare lanes 5 <br /> pected, colocalization CITFA-7 CITFA-2 (Fig. 4B) showed              6). This result mirrored depletion CITFA-2 extract <br /> a greater overlap. The colocalization signal pro-         prepared cells exclusively expressed tagged CITFA-2 <br /> teins comprised 80% CITFA-2 signal 63%                    (lanes 1 2). Previously, reported RNA pol I transcrip- <br /> CITFA-7 signal (see Fig. S4), supporting conclusion                tion CITFA-2-depleted extract partially restored <br /> CITFA-7 bona fide subunit CITFA complex. The                    addition CITFA complex purified tagged <br /> greater, noncolocalized CITFA-7 signal indicate            CITFA-2 (1); here, result reproduced CITFA-2- <br /> CITFA complexes carry CITFA-2 subunit (see below).                      CITFA-7-depleted extracts (lanes 3 7). In contrast, add- <br />     In hands, detection ESB difficult, ob-            ing CITFA purified tagged CITFA-7 resulted in <br /> served extranucleolar spots 10% cells (n &#226;&#171;&#189; 174).            restoration VSG-trm transcription (lanes 4 8). Detec- <br /> Interestingly, spots observed RPB6z                tion CITFA-2 CITFA-7 proteins depleted re- <br /> CITFA subunit localizations. In rare cases, CITFA-7 colocal-          stored extracts showed amounts proteins added to <br /> ized RPB6z CITFA-2 outside nucleolus, raising            extract comparable respective protein levels mock- <br /> the possibility transcription initiation factor CITFA           depleted extracts (Fig. 5, middle panel). Moreover, <br />  <br />  <br /> 1578   ec.asm.org                                                                                                                        Eukaryotic Cell <br />                                                                                                                      A Novel CITFA Subunit T. brucei <br />  <br />  <br />  <br /> these immunoblots revealed CITFA-2 depletion did not <br /> codeplete CITFA-7 (lane 2) CITFA-7 depletion led to <br /> efficient codepletion CITFA-2 (lane 6). Since major differ- <br /> ence CITFA-2 CITFA-7 purifications pres- <br /> ence CITFA-7 complex, results confirmed that <br /> CITFA-7 essential component CITFA. <br />     The increased functionality CITFA-7-purified complex <br /> also apparent electrophoretic mobility shift assay. <br /> The PTP&#226;&#8364;&#8220;CITFA-2-purified complex, harboring little <br /> CITFA-7, bound VSG ES promoter efficiently the <br /> CITFA-7&#226;&#8364;&#8220;PTP-purified complex (see Fig. S5 supplemental <br /> material). This result indicate CITFA-7 function in <br /> binding CITFA VSG ES promoter (see Discussion). <br />     The transcriptional function T. brucei CITFA-7 species <br /> specific. Despite fact multifunctional RNA pol I sys- <br /> tem present trypanosomatids, T. cruzi, <br /> where RNA pol I exclusively transcribes RRNA copies other <br /> eukaryotes, RNA pol I CITFA subunits T. brucei <br /> are conserved trypanosomatids. This lack T. brucei- <br /> specific factor raises possibility T. <br /> brucei factors gained function evolution specific <br /> for VSG ES procyclin gene expression. To test possibility <br /> for CITFA-7, introduced C-terminally HA-tagged T. cruzi <br /> CITFA-7 transgene T. brucei CITFA-7 RNAi cell line that <br /> conditionally expressed dsRNA CITFA-7 3= UTR (Fig. 6A). <br /> In contrast equivalently tagged, RNAi-resistant T. brucei <br /> CITFA-7&#226;&#8364;&#8220;HA (Fig. 3A), T. cruzi CITFA-7&#226;&#8364;&#8220;HA rescue <br /> trypanosome proliferation (Fig. 6A), expression of <br /> the heterologous transgene affected mRNA (Fig.            FIG 6 Expression T. cruzi CITFA-7-HA transgene did rescue trypano- <br /> 6B) protein (Fig. 6C) levels. The RNA analysis BF cell        proliferation T. brucei CITFA-7 knockdown. (A) Culture growth <br />                                                                          BFs noninduced (-Dox) TbCITFA-7-silenced (&#226;&#171;&#185;Dox) cells ex- <br /> line showed abundances RNA pol I tran-             press TcCITFA-7-HA. (B) Ethidium bromide staining rRNA semiquan- <br /> scripts, rRNA VSG mRNA, strongly reduced                  titative RT-PCR analysis listed mRNAs 0, 24, 72 h doxycycline <br /> TbCITFA-7 silencing (Fig. 6B), indicating TcCITFA-7&#226;&#8364;&#8220;HA              induction. Note TbCITFA-7 mRNA targeted knockdown <br /> was generally unable function T. brucei background. Al-        (KD). (C) Immunoblot analysis whole-cell lysates prepared nonin- <br /> though surprising conserved transcription factor     duced cells cells induced 24 h. TbCITFA-7 TFIIB were <br />                                                                          detected polyclonal antibodies endogenous proteins, and <br /> related organism genus dysfunctional, species        TcCITFA-7&#226;&#8364;&#8220;HA detected monoclonal anti-HA antibody. (D) Sed- <br /> specificity function hallmark RNA pol I typi-      imentation extract ultracentrifugation 10 40% linear sucrose <br /> cally RNA pol II III systems. It previously     gradient. Fractions 4 20, taken bottom, analyzed im- <br /> shown closely related human               munoblotting. For comparison, sedimentations TEV protease (29 kDa), <br />                                                                          Taq DNA polymerase (95 kDa), IgG (150 kDa, 6.6S), TRF4-SNAPc-TFIIA <br /> murine systems, factor binds ribosomal core pro-            transcription factor complex (TST) (&#226;&#172;&#402;230 kDa) (30), apoferritin (AP) (444 <br /> moter, termed selectivity factor 1 (SL1) humans TIF-IB         kDa, 17S), thyroglobin (TG) (660 kDa, 19S) analyzed parallel <br /> the mouse, dysfunctional other&#226;&#8364;&#8482;s (10).            gradients (arrowheads). <br />     In final step, wanted specific defect of <br /> TcCITFA-7 T. brucei. Localization HA-tagged protein by <br /> indirect immunofluorescence (IF) microscopy con-          CITFA-2. This notion consistent finding that <br /> centrated nucleolus, expected CITFA subunit (see         substantial CITFA-7 signal did colocalize CITFA-2 in <br /> Fig. S6 supplemental material). Another possibility      IF analysis (Fig. 4B; Fig. S4). In contrast T. brucei <br /> TcCITFA-7 did assemble CITFA complex. To test            CITFA subunits, TcCITFA-7&#226;&#8364;&#8220;HA spread throughout <br /> this, sedimented transcription extract noninduced BF             gradient exhibiting strong sedimentation peak <br /> cells linear sucrose gradient. TbCITFA-7 detected        fractions 13 14. This sedimentation pattern showed <br /> top gradient unbound protein and,            TcCITFA-7&#226;&#8364;&#8220;HA efficiently incorporated full <br /> CITFA complex, concentrated peak fraction 13 (Fig.         CITFA complex. Formation partial CITFA complexes re- <br /> 6D, middle panel). The sedimentation profile TbCITFA-2             cruitment heat shock proteins incomplete protein as- <br /> the gradient closely resembled previous sedimentation             semblies account signal spread. An alternative expla- <br /> analysis (1), unbound protein peaking fraction 8             nation finding self-aggregation TcCITFA-7&#226;&#8364;&#8220;HA in <br /> CITFA-associated protein peaking fraction 14 (Fig. 6D,            extract. However, likely, self-aggregation typ- <br /> panel). Interestingly, finding revealed shift sedimen-   ically observed protein overexpression, avoided by <br /> tation fraction gradient CITFA-7 peak,          integrating TcCITFA-7-HA transgene endogenous <br /> which suggested distinct CITFA complexes           CITFA-7 locus. Furthermore, formation partial CITFA <br /> the extract: inactive complex CITFA-2 active           complexes explain correct nucleolar localization of <br />  <br />  <br /> December 2012 Volume 11 Number 12                                                                                                   ec.asm.org 1579 <br />  Nguyen et al. <br />  <br />  <br />  <br /> TcCITFA-7&#226;&#8364;&#8220;HA. In sum, sedimentation analysis suggested               equivalently generated CITFA-7 antibody, raised <br /> that inefficient formation fully assembled CITFA complex            recombinant full-length protein (see Materials and <br /> may reason TcCITFA-7&#226;&#8364;&#8220;HA rescue silencing            Methods; data shown). Although exclude the <br /> of endogenous CITFA-7. In addition, TcCITFA-7 appeared                possibility polyclonal antibody did recognize in- <br /> carry fewer posttranslational modifications TbCITFA-7 (Fig.         teraction domain CITFA-7, likely interpretation result <br /> 2B C, 3C, 6C D), contributed           CITFA-7&#226;&#8364;&#8482;s essential interactions occur complex <br /> failure heterologous protein function T. brucei        inaccessible antibody blockage. If true, CITFA-7&#226;&#8364;&#8482;s <br /> system.                                                                  main function correct assembly CITFA, notion <br />                                                                          supported finding CITFA-7, contrast to <br /> DISCUSSION                                                               CITFA-2, CITFA complexes extract. <br /> Here characterized seventh nondynein subunit                    Finally, confirmed trypanosomes RNA pol I <br /> CITFA termed it, accordingly, CITFA-7. The CITFA complex             prone rapid divergence closely related spe- <br /> is essential transcription ribosomal, VSG ES,           cies. Expression heterologous CITFA-7 gene T. cruzi <br /> procyclin gene promoters and, shown VSG ES promoter,          rescue knockdown endogenous CITFA-7 <br /> binds DNA sequence-dependent fashion (1). CITFA-7            gene. Our data strongly indicated TcCITFA-7 unable to <br /> not discovered previously tagging tandem affinity            assemble functional CITFA complex showed that, in <br /> purification CITFA-2 copurified minute amounts                comparison TbCITFA-7, carried fewer posttranslational <br /> CITFA-7 (1). Nevertheless, data clearly demonstrated            modifications. Interestingly, defect murine and <br /> CITFA-7 bona fide CITFA subunit essential proper        human RNA pol I systems attributed rapid divergence <br /> function protein complex. We showed CITFA-7             rDNA promoter sequence DNA-protein interaction <br /> is tagged depleted extract, trackable             core factors (10), results suggest Tc- <br /> CITFA subunits, 2 6, codepleted extracts, indicat-         CITFA-7 unable undergo correct complex assembly and <br /> ing subunits quantitatively bound CITFA-7.        obtain potentially important posttranslational modifications. <br /> Consistent CITFA-7 CITFA subunit, knockdown             These dramatic defects trypanosomes likely con- <br /> specifically affected abundance RNA pol I transcripts         sequence changes amino acid sequences trypano- <br /> rRNA VSG mRNA. Moreover, vitro assays unequivo-               somatid transcription factors diverged rapidly <br /> cally demonstrated importance CITFA-7 CITFA func-             than, example, trypanosomatid RNA processing factors (6, <br /> tion: CITFA-2-purified complex, comprised CITFA                7). Nevertheless, approach reconstituting CITFA function <br /> subunits CITFA-7, efficient CITFA-7-           vivo heterologous subunits subunit domains the <br /> purified complex restoring RNA pol I transcription CITFA-          potential uncover VSG procyclin gene-specific functions of <br /> depleted extracts binding VSG ES promoter gel shifts.      essential RNA pol I transcription factor complex. <br />     What specific function CITFA-7? We know. <br /> CITFA inherently difficult analyze sub-        ACKNOWLEDGMENTS <br /> units, lack sequence similarity mammalian yeast RNA        We grateful Barbara Burleigh (Harvard University) providing T. <br /> pol I transcription factors, lack known sequence motifs.      cruzi genomic DNA Sung Hee Park help generating the <br /> Mechanistically, RNA pol I transcription initiation conserved         anti-CITFA-6 immune serum. <br /> between yeast mammals (28). It involves formation            This project funded NIH grant R01 AI059377 (to A.G.). <br /> RNA pol I transcription preinitiation complex (PIC), a <br />                                                                          REFERENCES <br /> core promoter-binding factor recruits RNA pol I transcrip- <br />                                                                           1. Brandenburg J, et al. 2007. Multifunctional class I transcription in <br /> tion initiation site interaction enzyme-bound               Trypanosoma brucei depends novel protein complex. EMBO J. 26: <br /> factor RRN3. In yeast, factor termed core factor,            4856 &#226;&#8364;&#8220; 4866. <br /> humans termed SL1. In addition, distinct factor            2. Brun R, Blum J. 2012. Human African trypanosomiasis. Infect. Dis. Clin. <br /> binds upstream promoter element activates ribosomal                North Am. 26:261&#226;&#8364;&#8220;273. <br />                                                                           3. Chaves I, et al. 1998. Subnuclear localization active variant surface <br /> DNA (rDNA) transcription stabilizing PIC formation. The <br />                                                                              glycoprotein gene expression site Trypanosoma brucei. Proc. Natl. Acad. <br /> VSG ES promoter extends 67 bp upstream transcrip-                Sci. U. S. A. 95:12328 &#226;&#8364;&#8220;12333. <br /> tion initiation site consists short sequence elements          4. Ehlers B, Czichos J, Overath P. 1987. RNA turnover Trypanosoma <br /> (24, 34). Since elements required efficient binding          brucei. Mol. Cell. Biol. 7:1242&#226;&#8364;&#8220;1249. <br /> purified CITFA (1) close initiation site,    5. Grummt I, Skinner JA. 1985. Efficient transcription protein-coding <br />                                                                              gene RNA polymerase I promoter transfected cells. Proc. Natl. <br /> CITFA appears functional equivalent yeast core              Acad. Sci. U. S. A. 82:722&#226;&#8364;&#8220;726. <br /> factor human SL1. According known functions           6. G&#195;&#188;nzl A. 2010. The pre-mRNA splicing machinery trypanosomes: <br /> factors, CITFA-7 directly involved DNA binding                  complex simplified? Eukaryot. Cell 9:1159 &#226;&#8364;&#8220;1170. <br /> interact RRN3-like factor. However, think          7. G&#195;&#188;nzl A. 2012. RNA polymerases transcription factors trypano- <br />                                                                              somes, p 1&#226;&#8364;&#8220;27. In Bindereif A (ed), RNA metabolism trypanosomes, vol <br /> is case. Previously, able inhibit transcrip- <br />                                                                              28. Springer Press, Berlin, Germany. <br /> tional function RNA pol II transcription factor TFIIB           8. G&#195;&#188;nzl A, Bindereif A, Ullu E, Tschudi C. 2000. Determinants cap <br /> adding polyclonal anti-TFIIB antibody extract prior            trimethylation U2 small nuclear RNA conserved between <br /> vitro transcription reaction (30). Since RNA Pol II PIC formation            Trypanosoma brucei higher eukaryotic organisms. Nucleic Acids Res. <br /> requires TFIIB bind promoter, TATA-binding pro-                28:3702&#226;&#8364;&#8220;3709. <br />                                                                           9. G&#195;&#188;nzl A, Vanhamme L, Myler PJ. 2007. Transcription trypanosomes: <br /> tein, polymerase, appears antibody able           different means end, p 177&#226;&#8364;&#8220;208. In Barry JD, Mottram JC, Mc- <br /> interfere interactions. The function CITFA sim-            Culloch R, Acosta-Serrano A (ed), Trypanosomes&#226;&#8364;&#8221;after genome. <br /> ilarly inhibited antibody CITFA-2 (1)           Horizon Press, Pittsburgh, PA. <br />  <br />  <br />  <br /> 1580   ec.asm.org                                                                                                                         Eukaryotic Cell <br />                                                                                                                                   A Novel CITFA Subunit T. brucei <br />  <br />  <br />  <br /> 10. Heix J, Zomerdijk JC, Ravanpay A, Tjian R, Grummt I. 1997. Cloning              24. Pham VP, Qi CC, Gottesdiener KM. 1996. A detailed mutational analysis <br />     murine RNA polymerase I-specific TAF factors: conserved interactions             VSG gene expression site promoter. Mol. Biochem. Parasitol. 75: <br />     subunits species-specific transcription initiation factor        241&#226;&#8364;&#8220;254. <br />     TIF-IB/SL1. Proc. Natl. Acad. Sci. U. S. A. 94:1733&#226;&#8364;&#8220;1738.                       25. Roditi I, Clayton C. 1999. An unambiguous nomenclature major <br /> 11. Hertz-Fowler C, et al. 2008. Telomeric expression sites highly con-             surface glycoproteins procyclic form Trypanosoma brucei. Mol. <br />     served Trypanosoma brucei. PLoS One 3:e3527. doi:10.1371/                        Biochem. Parasitol. 103:99 &#226;&#8364;&#8220;100. <br />     journal.pone.0003527.                                                           26. Rudenko G, Chung HM, Pham VP, Van der Ploeg LH. 1991. RNA <br /> 12. Kawahara T, et al. 2008. Two essential MYST-family proteins display                 polymerase I mediate expression CAT neo protein-coding <br />     distinct roles histone H4K10 acetylation telomeric silencing try-         genes Trypanosoma brucei. EMBO J. 10:3387&#226;&#8364;&#8220;3397. <br />     panosomes. Mol. Microbiol. 69:1054 &#226;&#8364;&#8220;1068.                                       27. Ruepp S, et al. 1997. <span id='am-4' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-5' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-12' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-13' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-18' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-23' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-25' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-26' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-27' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-36' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-52' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-54' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-64' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-67' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-68' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-73' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-74' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span>Survival</span> Trypanosoma brucei tsetse fly is <br /> 13. Kelly S, Wickstead B, Gull K. 2005. An silico analysis trypanoso-             enhanced expression specific forms procyclin. J. Cell Biol. <br />     matid RNA polymerases: insights unusual transcription.                   137:1369 &#226;&#8364;&#8220;1379. <br />     Biochem. Soc. Trans. 33:1435&#226;&#8364;&#8220;1437.                                              28. Russell J, Zomerdijk JC. 2005. RNA-polymerase-I-directed rDNA tran- <br /> 14. Laufer G, Schaaf G, Bollg&#195;&#182;nn S, G&#195;&#188;nzl A. 1999. In vitro analysis                 scription, life works. Trends Biochem. Sci. 30:87&#226;&#8364;&#8220;96. <br />     alpha-amanitin-resistant transcription rRNA, procyclic acidic          29. Schimanski B, Brandenburg J, Nguyen TN, Caimano MJ, G&#195;&#188;nzl A. <br />     repetitive protein, variant surface glycoprotein gene promoters              2006. A TFIIB-like protein indispensable spliced leader RNA gene <br />     Trypanosoma brucei. Mol. Cell. Biol. 19:5466 &#226;&#8364;&#8220;5473.                                 transcription Trypanosoma brucei. Nucleic Acids Res. 34:1676 &#226;&#8364;&#8220;1684. <br /> 15. Luz Ambrosio D, et al. 2009. Spliceosomal proteomics Trypanosoma             30. Schimanski B, Nguyen TN, G&#195;&#188;nzl A. 2005. Characterization multi- <br />     brucei reveal new RNA splicing factors. Eukaryot. Cell 8:990 &#226;&#8364;&#8220;1000.                 subunit transcription factor complex essential spliced-leader RNA <br /> 16. Marcello L, Barry JD. 2007. Analysis VSG gene silent archive in <br />                                                                                         gene transcription Trypanosoma brucei. Mol. Cell. Biol. 25:7303&#226;&#8364;&#8220;7313. <br />     Trypanosoma brucei reveals mosaic gene expression prominent in <br />                                                                                     31. Schimanski B, Nguyen TN, G&#195;&#188;nzl A. 2005. Highly efficient tandem <br />     antigenic variation favored archive substructure. Genome Res. <br />                                                                                         affinity purification trypanosome protein complexes based nove <br /> </body></html>